Chronic Anergic-anhedonic Depression Open Trial

Last updated: October 25, 2023
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Treatment

N/A

Clinical Study ID

NCT06110507
8903
  • Ages > 18
  • All Genders

Study Summary

A form of depression called 'dopamine-sensitive anergic-anhedonic syndrome is usually resistant to standard therapies (TRAD). On the other hand, they respond to dopaminergic approaches for which recommendations have been developed: DATA ('Dopaminergic Antidepressant Therapy Algorithm'). These are two stages starting with non-selective monoamineoxidase inhibitors (MAOI) or dopamine D2 receptor agonists (D2RAG) in 'monotherapy' (DATA1) and proposing to combine them in the event of a partial response (DATA2).

The effectiveness of this approach in the management of TRAD has not yet been evaluated in routine care.

The aim of this study is to evaluate the feasibility and effectiveness in routine care of the DATA recommendations in the management of TRAD presenting to a specialized consultation for resistant depression (short and long-term results).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Major patient (≥18 years old)
  • Man or woman
  • Patient covered for consultation at the Expert Resistant Depression Center of Alsace (CEDRA) (CHU-Strasbourg branch) for TRAD between 01 January 2013 and 31 March 2023
  • Patient not opposing to the reuse of their data for the purposes of this research

Exclusion

Exclusion Criteria:

  • Patient having expressed opposition to participating in the study
  • Patient under judicial protection
  • Patient under guardianship or curatorship

Study Design

Total Participants: 60
Study Start date:
April 01, 2023
Estimated Completion Date:
March 22, 2024

Connect with a study center

  • CENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) - CHU de Strasbourg - France

    Strasbourg, 67091
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.